Press Releases

HOLON, Israel, Jan. 8, 2020 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced the appointment of Oliver Froescheis, Ph.D., as Senior Vice President, Corporate and Business Developmen

TEL AVIV, Israel, Jan. 8, 2020 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today that management will provide a corporate update at the 2020 Biotech Showcase in San Francisco, California.2020 Biotech Showcase Presentation Details:

NEW YORK, Jan. 8, 2020 /PRNewswire/ -- WindRose Health Investors, LLC ("WindRose"), the New York-based healthcare private equity firm, announced that it has completed the recapitalization of its portfolio company, Medical Knowledge Group, LLC ("Medical Knowledge Group" or the "Company"), by investment funds managed by Court Square Ca

SHANGHAI and PHILADELPHIA, Jan. 8, 2020 /PRNewswire/ -- The Antengene board today announced the appointment of Mr. Mark J. Alles as an independent director of the company, effective January 2, 2020. Mr. Alles is the former Chairman and Chief Executive Officer of Celgene Corporation, now a subsidiary of

ALPHARETTA, Ga., Jan. 8, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday Jan. 15 at approximately 2 p.m. PT at the Westin S

CHICAGO, Jan. 8, 2020 /PRNewswire/ -- Kaizen Health, Inc. today announced the completion of its Series B funding round led by UnityPoint Health Ventures, the venture investment arm of one of the nation's most integrated health systems. The investment supports Kaizen Health's efforts to streamline the experience of ordering non-emergency, multi-modal medical transpor

NEW YORK, Jan. 8, 2020 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced that its subsidiary, Immunic AG, under the terms of its existing option and license agreement with Daiichi Sankyo

PALO ALTO, Calif., Jan. 8, 2020 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, announced today that management will present a company overview at the J.P. Morgan Healthcare Conference in San Francisco, California

MINNEAPOLIS, Jan. 8, 2020 /PRNewswire/ -- Today, Bright Health, a diversified consumer-focused healthcare company, announced it has signed an agreement to acquire California-based Universal Care (d.b.a. Brand New Day) health plan. The transaction will combine Brand New Day's lo

NEW YORK and BASEL, Switzerland, Jan. 8, 2020 /PRNewswire/ -- Roivant Sciences today announced that Vivek Ramaswamy, Founder and Chief Executive Officer of Roivant, will present an overview of recent developments and future directions for the business at the 38th Annual J.P. Morgan Healthcare Conference in